Lian F Van Der Gang

8PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersAutoimmunityAllergyPharmacogenomicsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 25, 2026
Translating 6-year trial safety data of upadacitinib in atopic dermatitis into clinical practice.

|Apr 13, 2026
Dupilumab versus tralokinumab in atopic dermatitis: A propensity score adjusted comparison from BioDay.

Lian F van der Gang, Nicolaas P A Zuithoff, Inge M Haeck

|Jan 31, 2026
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis.

Lian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff

|Dec 09, 2025
Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.

Lian F van der Gang, Celeste M Boesjes, Nicolaas P A Zuithoff

|Nov 25, 2025
Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real-world evidence.

Lian F van der Gang, Marjolein S de Bruin-Weller

|Apr 03, 2025
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results.

Lian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff

Pageof 2